Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: September 25, 2017
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-501-00 | 100 CAPSULE in 1 BOTTLE (59572-501-00) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-501-21 | 21 CAPSULE in 1 BOTTLE (59572-501-21) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-502-00 | 100 CAPSULE in 1 BOTTLE (59572-502-00) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-502-21 | 21 CAPSULE in 1 BOTTLE (59572-502-21) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-503-00 | 100 CAPSULE in 1 BOTTLE (59572-503-00) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-503-21 | 21 CAPSULE in 1 BOTTLE (59572-503-21) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-504-00 | 100 CAPSULE in 1 BOTTLE (59572-504-00) | |||||||
Celgene | POMALYST | pomalidomide | CAPSULE;ORAL | 204026 | NDA | Celgene Corporation | 59572-504-21 | 21 CAPSULE in 1 BOTTLE (59572-504-21) | |||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Follow DrugPatentWatch:
Join the 22,766 others who get our Drug Patent Expiration Alerts:
